Gabizon, Alberto A. http://orcid.org/0000-0003-1332-1164
Tahover, Esther
Golan, Talia
Geva, Ravit
Perets, Ruth
Amitay, Yasmine
Shmeeda, Hilary
Ohana, Patricia
Funding for this research was provided by:
Lipomedix Pharmaceuticals Ltd. (Bioanalytical testing of Promitil)
Article History
Received: 5 December 2019
Accepted: 10 January 2020
First Online: 18 January 2020
Compliance with ethical standards
:
: A. Gabizon is founder, chief scientist and a director of Lipomedix; E. Tahover declares that she has no conflict of interest; T. Golan declares that she has no conflict of interest; R. Geva declares that she has no conflict of interest; R. Perets declares that she has no conflict of interest; Y. Amitay is an employee (scientist) of Lipomedix; H. Shmeeda declares that she has no conflict of interest; P. Ohana is an employee (vice-president) of Lipomedix.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.